Missouri Hemp Regulation: Laws, Licensing, and Compliance Guide

Executive Summary

Missouri's hemp industry faces an existential crisis following the enactment of new state regulations that operators say effectively ban their businesses. In July 2026, multiple hemp companies filed legal challenges arguing that recent legislative changes to Missouri's hemp framework have eliminated the legal pathway for selling hemp-derived products containing delta-8 THC, delta-10 THC, and other intoxicating cannabinoids that previously operated in a regulatory gray zone. The new law, which took effect in 2026, establishes strict testing requirements, potency limits, and licensing frameworks that hemp businesses claim are impossible to meet without reclassifying as marijuana dispensaries. This regulatory shift affects hundreds of retailers, processors, and farmers across Missouri who built businesses around federally legal hemp products following the 2018 Farm Bill. The legal battle centers on whether Missouri can effectively prohibit products that remain legal under federal law, and whether the state's approach violates interstate commerce protections. With millions of dollars in business investment at stake and thousands of jobs hanging in the balance, the outcome will determine whether Missouri's hemp market continues to exist as a distinct industry or becomes absorbed entirely into the state's licensed marijuana program.

Why This Matters

The Missouri hemp regulation dispute affects a multi-million dollar industry serving consumers who prefer hemp-derived products over state-licensed marijuana. According to industry estimates, Missouri's hemp retail sector generated approximately $150-200 million in annual sales prior to the new regulations, supporting an estimated 2,000-3,000 jobs across retail, manufacturing, and agriculture. The regulatory crackdown impacts several key stakeholder groups with competing interests. Hemp retailers and processors face immediate business closure if the new regulations stand. Many operators invested substantial capital in storefronts, extraction equipment, and inventory based on the legal framework established after the 2018 Farm Bill legalized hemp at the federal level. These businesses argue they operated in good faith compliance with both federal law and Missouri's previous hemp regulations. Licensed marijuana dispensaries, conversely, support stricter hemp regulation. Missouri's adult-use marijuana program, approved by voters through Amendment 3 in November 2022, created a licensed and taxed market where products undergo mandatory testing and retailers pay significant licensing fees. Marijuana operators argue that unregulated hemp stores selling intoxicating products create unfair competition and undermine public health protections. Consumers represent a third stakeholder group. Many customers prefer hemp-derived delta-8 THC and similar cannabinoids because they produce milder psychoactive effects than delta-9 THC found in marijuana. Others choose hemp products because they remain legal under federal law, which matters for employment drug testing and interstate travel. Price differences also factor significantly—hemp products typically cost 30-50% less than equivalent marijuana products due to lower regulatory overhead. Agricultural producers face uncertainty about which crops remain viable. Missouri farmers planted approximately 3,000-4,000 acres of hemp in 2025, with much of that biomass destined for cannabinoid extraction rather than fiber or seed production. If processors can no longer legally purchase hemp for intoxicating cannabinoid production, farmers lose a major market channel. State regulators must balance competing mandates: implementing voter-approved marijuana legalization, maintaining public health standards, respecting federal hemp law, and supporting agricultural development. The Missouri Department of Agriculture oversees hemp cultivation, while the Department of Health and Senior Services regulates marijuana, creating jurisdictional complexity.

Background and History

Missouri's hemp regulatory conflict emerged from the collision between federal hemp legalization, state marijuana policy, and the rise of intoxicating hemp-derived cannabinoids.

Federal Hemp Legalization (2014-2018)

The 2014 Farm Bill first allowed states to establish hemp pilot programs for research purposes. Missouri did not immediately participate, maintaining hemp's status as a controlled substance under state law. The 2018 Farm Bill, signed December 20, 2018, removed hemp from the Controlled Substances Act's definition of marijuana, legalizing cultivation, processing, and sale of cannabis plants containing no more than 0.3% delta-9 THC on a dry weight basis. This federal change created the legal foundation for hemp commerce nationwide.

Missouri Hemp Legalization (2018-2019)

Missouri lawmakers responded to federal hemp legalization by passing House Bill 2034 in 2018, which Governor Mike Parson signed into law. The legislation established a state hemp program administered by the Missouri Department of Agriculture, creating licensing frameworks for hemp cultivation and processing. The law took effect August 28, 2018, making Missouri one of the earlier states to align with the 2018 Farm Bill. Missouri's initial hemp regulations focused primarily on agricultural production rather than finished consumer products. The state required hemp farmers to obtain licenses and submit crop samples for THC testing to verify compliance with the 0.3% delta-9 THC threshold. However, the regulatory framework did not anticipate the explosion of hemp-derived intoxicating cannabinoids that would emerge in subsequent years.

The Delta-8 THC Phenomenon (2019-2021)

Beginning around 2019, manufacturers discovered they could convert CBD extracted from legal hemp into delta-8 THC through chemical processes. Delta-8 THC is a naturally occurring cannabinoid found in trace amounts in cannabis, but commercial products typically contain synthesized delta-8 created through isomerization of CBD. The compound produces psychoactive effects similar to but generally milder than delta-9 THC. Because delta-8 THC is technically not delta-9 THC, and because it can be derived from federally legal hemp, manufacturers argued these products fell outside controlled substance laws. Missouri hemp retailers began selling delta-8 THC products in various forms—vape cartridges, edibles, tinctures, and flower—without state licensing requirements or product testing. The delta-8 market expanded rapidly across Missouri from 2020-2022. Retailers opened in strip malls, gas stations, and standalone storefronts, particularly in areas without licensed marijuana dispensaries. Product variety expanded beyond delta-8 to include delta-10 THC, THC-O, HHC (hexahydrocannabinol), and other novel cannabinoids created through chemical synthesis or extraction.

Medical Marijuana Implementation (2018-2020)

Parallel to hemp legalization, Missouri voters approved Amendment 2 in November 2018, legalizing medical marijuana. The Missouri Department of Health and Senior Services began accepting license applications in 2019 and the first dispensaries opened in October 2020. The medical program established comprehensive regulations including product testing for potency and contaminants, child-resistant packaging, dosage limits, and strict licensing requirements for cultivation, manufacturing, testing, and retail. Licensed marijuana operators immediately identified hemp-derived intoxicating products as competitive threats. A delta-8 vape cartridge sold at a hemp shop for $25-30 competed directly with a delta-9 THC cartridge at a dispensary selling for $50-60, despite neither requiring a medical card. Marijuana licensees argued this created an unlevel playing field where they bore regulatory costs while hemp operators avoided testing, licensing fees, and taxation.

Adult-Use Marijuana Legalization (2022)

Missouri voters approved Amendment 3 on November 8, 2022, legalizing adult-use marijuana for individuals 21 and older. The amendment took effect December 8, 2022, making Missouri the 21st state to legalize recreational marijuana. Amendment 3 expanded the existing medical framework to allow adult-use sales through the same licensed dispensaries, with additional tax revenue directed to expungement programs, veterans services, and drug treatment. The amendment's passage intensified the regulatory conflict with hemp. Marijuana advocates argued that voters intended to create a regulated market for intoxicating cannabis products, and that unregulated hemp products undermined that intent. Hemp operators countered that Amendment 3 addressed marijuana specifically and did not grant authority to restrict federally legal hemp.

Legislative Action (2023-2026)

The Missouri General Assembly began considering hemp regulation bills in 2023. Early proposals sought to ban synthetic cannabinoids like delta-8 THC or bring hemp-derived intoxicating products under the marijuana regulatory framework. These efforts faced opposition from hemp industry advocates and some agricultural groups who argued that overly restrictive regulations would harm farmers and small businesses. Negotiations continued through the 2024 and 2025 legislative sessions. Competing bills proposed different approaches: some would have banned all intoxicating hemp products, others would have created a separate regulatory tier, and still others focused on age restrictions and labeling requirements without prohibiting sales. The legislation that ultimately passed in 2026 represented a compromise that hemp operators say effectively functions as a ban. The new law established mandatory testing requirements for all hemp products sold in Missouri, imposed potency limits on intoxicating cannabinoids, required retailers to obtain state licenses, and mandated compliance with packaging and labeling standards similar to those governing marijuana products. Critically, the law also restricted where hemp products could be sold and prohibited certain synthetic cannabinoids entirely.

Legal Challenges Filed (July 2026)

Within weeks of the new regulations taking effect, multiple hemp companies filed lawsuits in Missouri state court challenging the law's constitutionality and implementation. The complaints argue that the regulations violate the Supremacy Clause of the U.S. Constitution by conflicting with federal hemp law, impose impossible compliance burdens that function as a de facto ban, and exceed the state's regulatory authority over federally legal agricultural products.

Key Players

Missouri Department of Agriculture

The Department of Agriculture administers Missouri's hemp program, including licensing hemp farmers and processors. The agency has issued approximately 500-700 hemp cultivation licenses since 2019, though the number of active growers fluctuates based on market conditions. Following passage of the new regulations, the Department faces the challenge of implementing testing and compliance requirements for finished hemp products, an area outside its traditional agricultural oversight role. Director Chris Chinn has emphasized the department's commitment to supporting Missouri farmers while ensuring compliance with both state and federal law.

Missouri Department of Health and Senior Services

The Department of Health and Senior Services regulates Missouri's medical and adult-use marijuana programs. The agency oversees approximately 380 licensed marijuana facilities statewide, including cultivation operations, manufacturing facilities, testing laboratories, and dispensaries. The department has supported stricter hemp regulation, arguing that intoxicating products should meet the same safety and testing standards regardless of whether they derive from hemp or marijuana. The agency's testing protocols require analysis for potency, pesticides, heavy metals, microbial contaminants, and residual solvents.

Hemp Industry Plaintiffs

The companies filing legal challenges include retailers, processors, and distributors who built businesses around hemp-derived cannabinoid products. These operators argue they invested in good faith reliance on federal hemp legalization and Missouri's initial regulatory framework. Many expanded rapidly during 2020-2023, opening multiple locations and hiring staff. The new regulations impose licensing fees, testing costs, and compliance requirements that plaintiffs say are economically impossible for businesses operating on hemp's lower profit margins compared to licensed marijuana.

Missouri Cannabis Trade Association

The Missouri Cannabis Trade Association represents licensed marijuana businesses and has advocated for stricter hemp regulation. The organization argues that intoxicating products should be sold only through licensed, tested, and regulated channels regardless of source material. The association supported the 2026 legislation and opposes legal challenges seeking to overturn it. Executive leadership has emphasized consumer safety concerns, noting that unregulated hemp products may contain contaminants or inaccurate potency labeling.

Missouri Farm Bureau

The Missouri Farm Bureau represents agricultural producers, including hemp farmers. The organization has taken a nuanced position, supporting farmers' ability to grow hemp as a legal crop while acknowledging legitimate concerns about intoxicating products. The Farm Bureau has advocated for regulations that preserve market channels for hemp biomass while addressing public health and safety issues. The organization represents approximately 100,000 member families across Missouri's 114 counties.

Missouri General Assembly

State legislators from both parties participated in crafting the 2026 hemp regulations. Sponsors argued the legislation was necessary to close loopholes allowing unregulated intoxicating products to reach consumers, particularly minors. Rural legislators expressed concerns about impacts on agricultural producers, while urban representatives emphasized consumer protection. The bill passed with bipartisan support, though significant opposition remained from hemp industry advocates and libertarian-leaning lawmakers.

Legal and Regulatory Framework

Missouri's hemp regulatory conflict involves the interaction of federal law, state statutes, voter-approved constitutional amendments, and administrative regulations.

Federal Law: The 2018 Farm Bill

The Agriculture Improvement Act of 2018, commonly called the 2018 Farm Bill, amended the Controlled Substances Act to exclude hemp from the definition of marijuana. Section 10113 of the Act defines hemp as "the plant Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis." This definition appears in 7 U.S.C. § 1639o. The law explicitly states that hemp is not a controlled substance and that no federal law prohibits the interstate commerce of hemp. This federal legalization created the foundation for hemp businesses nationwide. However, the law also preserved state authority to regulate hemp more restrictively than federal standards, stating that states may prohibit hemp production or establish more stringent regulations.

Missouri State Law: Hemp Production Act

Missouri's hemp program operates under Chapter 195 of the Missouri Revised Statutes, specifically sections 195.010 through 195.777. The original 2018 legislation established licensing requirements for hemp cultivation and processing, defined hemp using the federal 0.3% delta-9 THC threshold, and created enforcement mechanisms for non-compliant crops. The 2026 amendments significantly expanded the regulatory framework. New provisions require all hemp products containing intoxicating cannabinoids to undergo testing by state-licensed laboratories, impose a 10 mg THC limit per serving for edible products, mandate child-resistant packaging, require age verification for sales, and establish a licensing system for hemp retailers. The law also prohibits synthetic cannabinoids created through chemical processes not naturally occurring in the plant.

Missouri Constitution: Amendment 3

Amendment 3, approved by voters in November 2022, amended Article XIV of the Missouri Constitution to legalize adult-use marijuana. The amendment grants the Department of Health and Senior Services authority to regulate marijuana cultivation, manufacturing, testing, and sales. Section 1(3) defines marijuana as "all parts of the plant genus cannabis, whether growing or not, the seeds thereof, the resin extracted from any part of such plant; and every compound, manufacture, salt, derivative, mixture, or preparation of such plant, its seeds or resin" with exceptions for hemp as defined by federal law. This constitutional language creates tension with hemp regulation. Amendment 3 explicitly excludes hemp from its marijuana definition, yet hemp-derived intoxicating products compete directly with constitutional marijuana products. The amendment does not grant explicit authority to regulate hemp, raising questions about whether statutory hemp restrictions conflict with the constitutional framework.

Interstate Commerce Clause

The Commerce Clause of the U.S. Constitution, Article I, Section 8, Clause 3, grants Congress power to regulate interstate commerce. The Dormant Commerce Clause doctrine, developed through Supreme Court precedent, prohibits states from discriminating against or unduly burdening interstate commerce. Hemp industry plaintiffs argue that Missouri's regulations violate this doctrine by effectively prohibiting products that are legal under federal law and lawfully produced in other states. Missouri could counter that its regulations serve legitimate local interests in public health and safety, fall within the state's police powers, and do not discriminate against out-of-state commerce since they apply equally to in-state hemp producers. The legal analysis turns on whether the regulations are protectionist measures favoring Missouri's marijuana industry or legitimate health and safety rules.

Administrative Regulations

The Missouri Department of Agriculture has promulgated detailed regulations implementing the hemp program, codified in 2 CSR 70-2. These regulations specify licensing procedures, testing protocols, THC testing methodologies, and enforcement procedures. The 2026 statutory changes require the department to develop new regulations addressing finished product testing, retail licensing, and compliance verification. As of July 2026, emergency rules were filed to implement immediate requirements while permanent rulemaking proceeds.

State-by-State Breakdown

Missouri's approach to hemp regulation exists within a patchwork of varying state policies nationwide, with no uniform national standard for hemp-derived intoxicating products.

Missouri

Missouri now requires hemp products containing intoxicating cannabinoids to meet testing, packaging, and licensing requirements similar to marijuana products. Retail sales require state licenses, products must be tested by licensed laboratories, and synthetic cannabinoids are prohibited. Possession limits mirror marijuana rules: 3 ounces for adults 21 and older. The regulations took effect in 2026 and face active legal challenges.

Colorado

Colorado established comprehensive hemp regulations in 2019 following federal legalization. The state requires hemp products containing intoxicating cannabinoids to be sold only through licensed marijuana dispensaries, effectively treating them as marijuana regardless of source material. This approach eliminated a separate hemp retail market for intoxicating products. Colorado's regulations have withstood legal challenges, with courts finding the state has authority to regulate intoxicating substances regardless of federal hemp law.

California

California prohibits the sale of hemp-derived intoxicating cannabinoids outside the licensed marijuana system. Assembly Bill 45, signed in 2023, banned hemp products containing detectable amounts of THC from being sold outside licensed cannabis retailers. The law also prohibited adding cannabinoids to food products sold outside the cannabis system. California's approach treats any intoxicating cannabinoid as cannabis subject to state marijuana regulations.

Texas

Texas has taken a more permissive approach, allowing hemp-derived delta-8 THC and similar products to be sold with minimal regulation. The state's hemp program, established in 2019, does not prohibit hemp-derived intoxicating cannabinoids. However, the Texas Department of State Health Services has issued guidance stating that delta-8 THC products are illegal, creating legal uncertainty. Retailers continue operating despite this guidance, and enforcement has been inconsistent. Legislative efforts to clarify the law have stalled in multiple sessions.

North Carolina

North Carolina permits hemp-derived intoxicating products with minimal state regulation beyond federal hemp requirements. The state's hemp program focuses on agricultural production, and finished products face few restrictions. This has created a robust hemp retail market, particularly in areas without medical marijuana access. North Carolina has not legalized marijuana for medical or adult use, making hemp products the only legal option for consumers seeking cannabinoids.

Oregon

Oregon requires hemp products containing intoxicating cannabinoids to be sold through the state's licensed marijuana system. House Bill 3000, passed in 2021, brought hemp-derived intoxicating products under the Oregon Liquor and Cannabis Commission's regulatory authority. Products must meet the same testing, packaging, and labeling requirements as marijuana. The law effectively eliminated a separate hemp market for intoxicating products while preserving hemp cultivation for CBD and other non-intoxicating uses.

Florida

Florida allows hemp-derived delta-8 THC and similar products with age restrictions but minimal other regulation. The state's hemp program, established in 2019, does not prohibit intoxicating hemp derivatives. However, the Florida Department of Agriculture has issued conflicting guidance, and some local jurisdictions have banned delta-8 sales. The regulatory landscape remains uncertain, with ongoing legislative debates about whether to ban or regulate these products more strictly.

Market and Business Implications

Missouri's hemp regulations threaten to eliminate a market segment worth an estimated $150-200 million annually while potentially benefiting licensed marijuana operators. The economic impact falls disproportionately on small businesses. Most hemp retailers operate single locations with fewer than 10 employees, contrasting with multi-state operators (MSOs) that dominate Missouri's licensed marijuana market. The compliance costs for testing, licensing, and packaging requirements represent a larger percentage of revenue for small hemp operators than for established marijuana businesses with existing compliance infrastructure. Licensed marijuana dispensaries stand to gain market share if hemp competitors close. Missouri's approximately 200 active dispensaries could absorb customers who previously purchased hemp products. However, this assumes customers will pay higher prices for tested marijuana products rather than seeking unregulated alternatives or ceasing consumption. Industry analysts estimate that 30-40% of hemp customers may not transition to licensed dispensaries due to price sensitivity. Testing laboratory capacity presents a bottleneck. Missouri has approximately 15 licensed marijuana testing laboratories, but these facilities prioritize marijuana products from licensed operators who are required customers. Adding hemp product testing would require laboratories to expand capacity, hire additional staff, and potentially deprioritize marijuana testing. Laboratory operators report that testing costs for hemp products would need to be $200-400 per batch to be economically viable, costs that hemp operators say they cannot absorb. Hemp farmers face market uncertainty. Missouri's 3,000-4,000 acres of hemp cultivation in 2025 primarily served the cannabinoid extraction market rather than fiber or grain production. If processors cannot legally purchase hemp for intoxicating cannabinoid production, farmers lose a primary buyer. Some may shift to CBD production for non-intoxicating products, but that market faces its own challenges including oversupply and low wholesale prices. CBD biomass prices dropped from approximately $400-500 per pound in 2019 to $20-40 per pound in 2025. Tax revenue implications remain unclear. Licensed marijuana sales generate substantial tax revenue for Missouri through the 6% adult-use marijuana tax plus standard sales taxes. Hemp products previously generated only standard sales tax revenue. If hemp customers transition to licensed dispensaries, state tax revenue could increase by an estimated $8-12 million annually. However, if customers cease purchasing or seek unregulated alternatives, the state gains no additional revenue while losing existing sales tax collections. Employment impacts extend beyond retail. The hemp industry supports jobs in cultivation, processing, manufacturing, distribution, and retail. Industry estimates suggest 2,000-3,000 Missouri jobs depend on hemp-derived cannabinoid products. If regulations force business closures, these workers would need to find employment elsewhere. Some may transition to licensed marijuana businesses, but the licensed market cannot absorb all displaced workers. Real estate markets in areas with hemp retail concentrations face potential disruption. Some commercial landlords leased space to hemp retailers at premium rates during the industry's rapid expansion. If these tenants close, landlords must find replacement tenants in a potentially softer retail market. Conversely, licensed marijuana dispensaries may expand into newly available retail space, though zoning restrictions limit where dispensaries can operate. Investment capital has largely exited the hemp-derived cannabinoid sector. Venture capital and private equity firms that invested in hemp businesses from 2019-2022 have written down many positions as regulatory uncertainty increased. The Missouri regulatory changes reinforce investor skepticism about hemp's long-term viability as a distinct market segment. Capital is flowing instead to licensed marijuana operators and to CBD companies focused on non-intoxicating wellness products.

What Experts Say

Legal scholars, industry analysts, and policy experts offer divergent perspectives on Missouri's hemp regulations and their legal foundation. Cannabis law attorneys representing hemp companies argue the regulations violate the Supremacy Clause by conflicting with federal hemp law. According to legal analysis from hemp industry counsel, the 2018 Farm Bill explicitly legalized hemp and hemp derivatives, and Missouri cannot prohibit what federal law permits. These attorneys point to the Farm Bill's language stating that hemp is not a controlled substance and that no federal law prohibits interstate commerce in hemp. They argue Missouri's regulations function as a prohibition by imposing impossible compliance requirements. Constitutional law experts note that states retain police powers to regulate for health and safety even when federal law permits an activity. According to academic analysis, the 2018 Farm Bill preserved state authority to regulate hemp more restrictively than federal standards. States have successfully defended regulations that effectively prohibit intoxicating hemp products by framing them as health and safety measures rather than agricultural regulations. Courts have generally upheld state authority to regulate intoxicating substances regardless of source material. Public health researchers emphasize concerns about unregulated intoxicating products. According to toxicology studies, delta-8 THC products have been found to contain contaminants including heavy metals, pesticides, and residual solvents from the chemical conversion process. Without mandatory testing, consumers cannot verify product safety or potency accuracy. Research has documented cases of delta-8 products containing significantly more THC than labeled, creating risks of overconsumption and adverse reactions. Agricultural economists note that hemp regulation uncertainty has depressed farmer participation. According to USDA data, national hemp cultivation peaked at approximately 146,000 acres in 2019 but declined to roughly 54,000 acres by 2023 as market conditions deteriorated. Regulatory instability contributed to this decline by creating uncertainty about market channels for hemp biomass. Farmers need predictable regulations to make multi-year planting decisions and capital investments. Industry analysts observe that the hemp-derived cannabinoid market emerged from regulatory arbitrage rather than consumer demand for a distinct product category. According to market research, most consumers do not distinguish between delta-8 THC and delta-9 THC based on source material; they respond primarily to price, availability, and legal status. As states close the regulatory gap between hemp and marijuana, the economic rationale for a separate hemp market diminishes. Policy advocates from marijuana reform organizations support bringing intoxicating products under comprehensive regulation regardless of source. According to statements from legalization advocacy groups, the goal of marijuana policy reform is to create safe, regulated markets that protect consumers and generate tax revenue. Unregulated hemp products undermine these objectives by offering cheaper alternatives without safety oversight. These advocates argue that all intoxicating cannabis products should meet the same standards. Hemp industry trade associations counter that excessive regulation will drive consumers to unregulated black markets rather than licensed dispensaries. According to industry surveys, price sensitivity is the primary factor for many hemp consumers. If legal options become too expensive due to regulatory costs, consumers may seek unregulated alternatives from unlicensed sources. This outcome would harm both public health and state revenue objectives.

What's Next

The legal and regulatory future of Missouri hemp hinges on court decisions, potential legislative amendments, and federal policy developments expected to unfold over the next 12-24 months. The lawsuits filed by hemp companies in July 2026 will proceed through Missouri state courts. Initial hearings on motions for preliminary injunctions are expected in August-September 2026. If courts grant injunctions, hemp businesses could continue operating under previous rules while litigation proceeds. If courts deny injunctions, businesses face immediate compliance deadlines or closure. The legal process could extend 18-24 months before final resolution, with potential appeals to the Missouri Supreme Court. The Missouri General Assembly could amend the regulations during the 2027 legislative session beginning in January. Lawmakers may respond to legal challenges or business closures by modifying compliance timelines, adjusting testing requirements, or creating a separate regulatory tier for hemp products. However, any amendments would require navigating the same political dynamics that produced the 2026 legislation, with marijuana industry interests favoring strict regulation and hemp advocates seeking more permissive rules. Federal policy changes could reshape the entire landscape. The U.S. Food and Drug Administration has indicated it is developing regulations for CBD and other hemp-derived cannabinoids, though no timeline has been announced. If the FDA establishes federal standards for hemp products, states may align their regulations accordingly. Additionally, if Congress amends the Farm Bill to address intoxicating hemp derivatives, state laws would need to conform to new federal requirements. The Drug Enforcement Administration's ongoing review of marijuana scheduling could indirectly impact hemp regulation. If the DEA reschedules marijuana from Schedule I to Schedule III under the Controlled Substances Act, as recommended by the Department of Health and Human Services in 2023, the regulatory distinction between hemp and marijuana could narrow. Rescheduling would not legalize marijuana at the federal level but could influence state policy debates. Market consolidation appears likely regardless of legal outcomes. Smaller hemp operators lacking capital to meet compliance requirements may exit the market, while larger operators with resources to navigate regulations could acquire distressed assets. This pattern mirrors consolidation in state marijuana markets, where initial license proliferation gave way to concentration among well-capitalized operators. Consumer behavior will ultimately determine market viability. If customers prove willing to pay higher prices for tested, regulated products, a compliant hemp market could survive. If price sensitivity drives consumers to unregulated alternatives or licensed marijuana dispensaries, the hemp market may disappear as a distinct segment. Early sales data from the months following the regulation's implementation will provide critical indicators. Other states are watching Missouri's approach as they consider their own hemp regulations. Approximately 15-20 states currently allow hemp-derived intoxicating products with minimal regulation. If Missouri's regulations survive legal challenges and successfully channel consumers to licensed markets, other states may adopt similar frameworks. Conversely, if regulations trigger business closures without corresponding increases in licensed marijuana sales, states may seek alternative approaches.

Further Reading

• Agriculture Improvement Act of 2018 (2018 Farm Bill), Public Law 115-334, full text available at https://www.congress.gov/bill/115th-congress/house-bill/2
• Missouri Revised Statutes Chapter 195, Hemp Production Act, available at https://revisor.mo.gov/main/OneChapter.aspx?chapter=195
• Missouri Constitution Article XIV, Amendment 3 (Adult-Use Marijuana Legalization), full text at https://www.sos.mo.gov/elections/petitions/2022BallotMeasures
• Missouri Department of Agriculture Hemp Program regulations, 2 CSR 70-2, available at https://www.sos.mo.gov/adrules/csr/current/2csr/2csr.asp
• Missouri Department of Health and Senior Services Medical Marijuana Program regulations, 19 CSR 30-95, available at https://health.mo.gov/safety/medical-marijuana/
• USDA Hemp Production Program regulations, 7 CFR Part 990, available at https://www.ams.usda.gov/rules-regulations/hemp
• Congressional Research Service, "The 2018 Farm Bill: Hemp Production and the Federal-State Regulatory Framework," updated reports at https://crsreports.congress.gov
• National Conference of State Legislatures, "State Industrial Hemp Statutes," tracking database at https://www.ncsl.org/agriculture-and-rural-development/state-industrial-hemp-statutes
• FDA statements on CBD and hemp-derived products, available at https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products
• DEA Controlled Substances Schedules, 21 U.S.C. § 812, available at https://www.deadiversion.usdoj.gov/schedules/